News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pharsight Corporation (PHST) and FDA Collaboration Continues: CRADA Delivers Phoenix NLME and Phoenix Connect to Market


1/5/2010 9:28:00 AM

ST. LOUIS--(BUSINESS WIRE)--Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, today announced that it has released two new data analysis tools; Phoenix NLME and Phoenix Connect. The tools were developed via a collaborative effort between FDA and Pharsight under Pharsight’s previously-announced Cooperative Research and Development Agreement (CRADA) with FDA’s Center for Drug Evaluation and Research (CDER).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES